'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'

Michaela Schäfer¹, Christian U Oeing², Maria Rohm³, Ezgi Baysal-Temel², Lorenz H Lehmann², Ralf Bauer⁴, H Christian Volz⁵, Michael Boutros⁵, Daniela Sohn³, Carsten Sticht⁶, Norbert Gretz⁶, Katrin Eichelbaum⁷, Tessa Werner⁸, Marc N Hirt⁸, Thomas Eschenhagen⁸, Karin Müller-Decker⁹, Oliver Strobel¹⁰, Thilo Hackert¹⁰, Jeroen Krijgsveld¹¹, Hugo A Katus⁴, Mauricio Berriel Diaz³, Johannes Backs¹², Stephan Herzig¹³

Affiliations

¹ Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
² Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany.
³ Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
⁴ Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany.
⁵ Division of Signaling and Functional Genomics, German Cancer, Research Center (DKFZ), 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany.
⁶ Center for Medical Research, University of Mannheim, 68167, Mannheim, Germany.
⁷ Department for Cell Signaling and Mass Spectrometry, Max Delbrück Center, 13092, Berlin, Germany.
⁸ Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany.
⁹ Core Facility Tumor Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
¹⁰ Department of, General Surgery, University of Heidelberg, 69120, Heidelberg, Germany.
¹¹ Genome Biology Unit, EMBL, 69117, Heidelberg, Germany.
¹² Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany. Electronic address: johannes.backs@med.uni-heidelberg.de.
¹³ Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany. Electronic address: stephan.herzig@helmholtz-muenchen.de.

PMID: 32244184
PMCID: PMC7082542
DOI: 10.1016/j.molmet.2020.02.013

Published Erratum

'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'

Michaela Schäfer et al. Mol Metab. 2020 May.

. 2020 May:35:100970.

doi: 10.1016/j.molmet.2020.02.013. Epub 2020 Mar 4.

Authors

Affiliations

¹ Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
² Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany.
³ Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
⁴ Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany.
⁵ Division of Signaling and Functional Genomics, German Cancer, Research Center (DKFZ), 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany.
⁶ Center for Medical Research, University of Mannheim, 68167, Mannheim, Germany.
⁷ Department for Cell Signaling and Mass Spectrometry, Max Delbrück Center, 13092, Berlin, Germany.
⁸ Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany.
⁹ Core Facility Tumor Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
¹⁰ Department of, General Surgery, University of Heidelberg, 69120, Heidelberg, Germany.
¹¹ Genome Biology Unit, EMBL, 69117, Heidelberg, Germany.
¹² Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany. Electronic address: johannes.backs@med.uni-heidelberg.de.
¹³ Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany. Electronic address: stephan.herzig@helmholtz-muenchen.de.

PMID: 32244184
PMCID: PMC7082542
DOI: 10.1016/j.molmet.2020.02.013

No abstract available

PubMed Disclaimer

Figures

**Corrigendum Figure 1**
Correlation analyses of the different datasets comparing C26 and MC38 colon carcinoma cells. Correlation between (A) differentially expressed genes determined by RNAseq and the original (old) differential secretome analysis, (B) the original differential secretome analysis (old) and the new differential secretome analysis (new), (C) differentially expressed genes and the original (old) differential secretome analysis. Data are depicted as log2-fold changes (log2FC). Statistical analysis was performed by correlation analysis using Graphpad prism. N numbers, Pearson correlation coefficients (r) and statistical significance levels (p) are depicted in the graphs.

See this image and copyright information in PMC

Erratum for

Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia.
Schäfer M, Oeing CU, Rohm M, Baysal-Temel E, Lehmann LH, Bauer R, Volz HC, Boutros M, Sohn D, Sticht C, Gretz N, Eichelbaum K, Werner T, Hirt MN, Eschenhagen T, Müller-Decker K, Strobel O, Hackert T, Krijgsveld J, Katus HA, Berriel Diaz M, Backs J, Herzig S. Schäfer M, et al. Mol Metab. 2015 Nov 26;5(2):67-78. doi: 10.1016/j.molmet.2015.11.004. eCollection 2016 Feb. Mol Metab. 2015. PMID: 26909315 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'

Affiliations

'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'

Authors

Affiliations

Figures

Erratum for

Publication types

LinkOut - more resources

Full Text Sources